Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10098843
APP PUB NO 20160213618A1
SERIAL NO

15002498

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to the field of pharmaceutical chemistry and, more specifically, to pharmaceutical formulations as well as to intermediates used to prepare such formulations and to methods for manufacturing such formulations.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CYMABAY THERAPEUTICS INCNEWARK CA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Karpf, David B Monte Sereno, US 8 42
Ketner, Rodney James Bend, US 15 111
Lorenz, Douglas Alan Bend, US 21 72
Martin, Robert Louis Hayward, US 2 12
McWherter, Charles A Hayward, US 56 277
Roberts, Brian K Hayward, US 14 65

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 16, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 16, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00